DK1098891T3 - Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler - Google Patents

Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler

Info

Publication number
DK1098891T3
DK1098891T3 DK99934568T DK99934568T DK1098891T3 DK 1098891 T3 DK1098891 T3 DK 1098891T3 DK 99934568 T DK99934568 T DK 99934568T DK 99934568 T DK99934568 T DK 99934568T DK 1098891 T3 DK1098891 T3 DK 1098891T3
Authority
DK
Denmark
Prior art keywords
drugs
preparation
ylidene amines
thiazolidin
polycyclic
Prior art date
Application number
DK99934568T
Other languages
English (en)
Inventor
Gerhard Jaehne
Hans Jochen Lang
Karl Geisen
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1098891T3 publication Critical patent/DK1098891T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK99934568T 1998-07-17 1999-07-03 Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler DK1098891T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19831878A DE19831878C2 (de) 1998-07-17 1998-07-17 Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
DK1098891T3 true DK1098891T3 (da) 2005-12-12

Family

ID=7874197

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99934568T DK1098891T3 (da) 1998-07-17 1999-07-03 Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler

Country Status (25)

Country Link
US (1) US6159996A (da)
EP (1) EP1098891B1 (da)
JP (1) JP3541808B2 (da)
KR (1) KR20010083118A (da)
CN (1) CN1144797C (da)
AR (1) AR019925A1 (da)
AT (1) ATE301645T1 (da)
AU (1) AU767151B2 (da)
BR (1) BR9912151A (da)
CA (1) CA2337838A1 (da)
CL (1) CL2004000219A1 (da)
DE (2) DE19831878C2 (da)
DK (1) DK1098891T3 (da)
ES (1) ES2246089T3 (da)
HU (1) HUP0104942A3 (da)
ID (1) ID26985A (da)
IL (1) IL140767A (da)
NO (1) NO318790B1 (da)
NZ (1) NZ509395A (da)
PL (1) PL345619A1 (da)
PT (1) PT1098891E (da)
RU (1) RU2236405C2 (da)
TR (1) TR200100125T2 (da)
WO (1) WO2000004006A1 (da)
ZA (1) ZA200100279B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908538A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische 2-Amino-Thiazol Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908533A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
DE19908537A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen 2-Amino-Thiazol Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
CZ20021528A3 (cs) 1999-11-05 2002-07-17 Aventis Pharma Deutschland Gmbh Polycyklické deriváty dihydrothiazolu, způsob jejich přípravy a jejich pouľití jako léčiv
NZ520981A (en) * 2000-02-26 2004-08-27 Aventis Pharma Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
DE10142722A1 (de) 2001-08-31 2003-03-27 Aventis Pharma Deutschland GmbH, 65929 Frankfurt C2-substituierte Indan-1-one und ihre Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE10142665B4 (de) * 2001-08-31 2004-05-06 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-one und ihre Derivate
US7977532B2 (en) * 2002-09-05 2011-07-12 The Procter & Gamble Company Tampon with clean appearance post use
US8124582B2 (en) * 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
KR101186938B1 (ko) * 2004-07-09 2012-09-28 닛산 가가쿠 고교 가부시키 가이샤 올리고아닐린 화합물의 정제방법 및 올리고아닐린 화합물
WO2007054257A2 (en) * 2005-11-08 2007-05-18 Laboratorios Del Dr. Esteve, S.A. Indene derivatives, their preparation and use as medicaments
MX2010010659A (es) * 2008-03-31 2010-10-26 Genentech Inc Compuestos de benzopirano y benzoxepina, inhibidores de fosfoinoinositida 3-cinasas y metodos para utilizarlos.
WO2012124825A1 (en) 2011-03-16 2012-09-20 Mitsubishi Tanabe Pharma Corporation Sulfonamide compounds having trpm8 antagonistic activity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507868A (en) * 1968-10-21 1970-04-21 Sandoz Ag Imidazo(2,1-b)thiazoles and thiazolo(3,2-a)pyrimidines
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant

Also Published As

Publication number Publication date
CL2004000219A1 (es) 2005-04-22
NO20010219L (no) 2001-03-15
BR9912151A (pt) 2001-04-10
CN1309653A (zh) 2001-08-22
PL345619A1 (en) 2002-01-02
DE19831878A1 (de) 2000-01-27
RU2236405C2 (ru) 2004-09-20
HK1038560A1 (en) 2002-03-22
JP2002520404A (ja) 2002-07-09
NO20010219D0 (no) 2001-01-12
NZ509395A (en) 2003-10-31
ZA200100279B (en) 2001-08-07
AU767151B2 (en) 2003-10-30
DE59912402D1 (de) 2005-09-15
AR019925A1 (es) 2002-03-27
CA2337838A1 (en) 2000-01-27
KR20010083118A (ko) 2001-08-31
US6159996A (en) 2000-12-12
TR200100125T2 (tr) 2001-05-21
HUP0104942A2 (hu) 2002-04-29
JP3541808B2 (ja) 2004-07-14
DE19831878C2 (de) 2001-05-17
EP1098891B1 (de) 2005-08-10
IL140767A (en) 2005-12-18
NO318790B1 (no) 2005-05-09
IL140767A0 (en) 2002-02-10
AU5030899A (en) 2000-02-07
ID26985A (id) 2001-02-22
HUP0104942A3 (en) 2003-12-29
PT1098891E (pt) 2005-11-30
ATE301645T1 (de) 2005-08-15
EP1098891A1 (de) 2001-05-16
WO2000004006A1 (de) 2000-01-27
CN1144797C (zh) 2004-04-07
ES2246089T3 (es) 2006-02-01

Similar Documents

Publication Publication Date Title
DK1202733T3 (da) 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20012058L (no) 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
DK0740668T3 (da) Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse
NO20032733L (no) Difenylazetidinonderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse
NO991815L (no) Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter
NO963506D0 (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
DK1294682T3 (da) Acylphenylurinstofderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
DK1083171T3 (da) Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter
NO20016038D0 (no) Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
NO20011503D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler
NO20005146D0 (no) Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter
DK1095025T3 (da) Benzimidazoler, deres fremstilling og deres anvendelse som lægemidler
DK1045856T3 (da) Nye aromatiske amider, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
DK1261697T3 (da) Kuldeaktiv beta-galactosidase, fremgangsmåde til fremstilling heraf og anvendelsen deraf
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
DK1098891T3 (da) Polycycliske thiazolidin-2-yliden-aminer, fremgangsmåde til fremstilling deraf og deres anvendelse som lægemidler
DK1406899T3 (da) Phenylacetamidothiazolderivater, fremgangsmåder til deres fremstilling og deres anvendelse som antitumormidler
DK0903339T3 (da) Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament
NO20016404L (no) Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
DK0795547T3 (da) (Aminoalkyl- og acylaminoalkyl-oxy)benzyloxyquinoliner, fremgangsmåde til deres fremstilling og deres anvendelse som bradyk
DK0880524T3 (da) Adenosinantagonister, fremgangsmåde til fremstilling deraf og deres anvendelse som medikamenter
NO20015058L (no) Nye ribose-substituerte aromatiske amider, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler